Just published! #FromAcademia: 3D Printing for Neurosurgery Training, #VatPhotopolymerization 3D printing for advanced #drugdelivery #medicaldevice applications, #3dprinted soft robotic microsystem https://buff.ly/2J6q7ph⠀
In this issue, we included a user suitability study focusing on neurosurgical training using 3D printed anatomical models, an article exploring the actuation of 3D printed soft robotic microsystem, and a review paper discussing the current status and future potential of vat photopolymerization 3D printing in medical device and drug delivery space.
#Repost @glauber.rama
É... Olha só onde chegamos... Olhe a qualidade que um processo de impressão 3D de uma restauração provisória tem condições de chegar! Isso sem qualquer intervenção mecânica ainda, podendo e devendo ser ainda mais bem caracterizada mecanicamente e por meio de shades / glaze. Fica difícil competir com ela! Nossa incrível Phrozen Shuffle @odontomega mostrando que não está aí pra brincadeira! Faço isso há mais de um ano e ainda fico boquiaberto com os resultados quando ela finaliza até hoje... Simplesmente incrível! #phrozen3dp #impressao3d #dental3dprinting #odontomega #meshmixerdental #impressao3dodontologia #digitalsmiledesign
#Repost @sinaibiodesign
.
Playing with vascular structures #3dprinting #cerebrovascular #vascularmodeling #biodesign #anatomy
#Repost @sinaibiodesign
Phase 1 of a new project that combines 3D printing, molding and hydro-casting! This brain was made using our labs #projet3500 #sinaibiodesign #biodesign #brains #neurosurgery #MountSinaihospital #icahnschoolofmedicine
#Repost @farccotecnologia
.
Trabalho legal em #manufaturaaditiva https://www.linkedin.com/posts/juan-oliveira-2227a251_ortosintese-nautilus3d-freeformplus-activity-6677326495758852096-Pfqe
#Repost @farccotecnologia
.
Implante trabeculado fabricado por #manufaturaaditiva #ebm
#repost @professornaoshi Demostración de simulación clínica con realidad aumentada #nissin #simodont #enesleon #odontolife #instadental #dental #instastyle #instastyle #instagram #picoftheday #mexico #messico #mexique #メキシコ #メキシコ🇲🇽 #japon #japan #日本 #日本🇯🇵
#repost @copper3d_global #NanoHack #Maverick purple edition, ready to ship worldwide 🌎!
🚫🦠😷
@hackthepandemic.cl
#Repost @pmf.victororduna
.
Obtención de modelo de trabajo para rehabilitación protésica maxilofacial.
.
.
.
#maxillofacialprosthodontics #maxillofacialprosthetics #protesismaxilofacial #oncology #oncologia
#repost @envisiontec Create your own unique and organic patterns directly on the Visual Machine software. This piece was printed on the #EnvisionTEC 3D Bioplotter developer series using our Black Technical Grade Silicone material. It demonstrates different #pattern types you can create by using lines, zigzags, waves, and honeycombs. #developer #series #silicone #industrial #manufacturing
The Latest...
From Academia: 3D Printing for Neurosurgery Training, Vat Photopolymerization, soft robotic microsystem
“From Academia” features recent, relevant, close to commercialization academic publications in the space of healthcare 3D printing, 3D bioprinting, and related emerging technologies. In this...
3D Printing Against COVID19 (Updated Press Collection)
This is a weekly updated collection of press articles on innovations using 3D printing against COVID-19, complementing our existing COVID19 3D Printing information page, which includes our webinar...
From Academia: 3D Printed Lens, Silk as Biomaterial, Aspiration-assisted freeform bioprinting
“From Academia” features recent, relevant, close to commercialization academic publications in the space of healthcare 3D printing, 3D bioprinting, and related emerging technologies. In...
The Lattice #66: Healthcare 3D Printing Newsletter
The Lattice is 3DHEALS weekly recap of the latest news, publications, events in the world of healthcare 3D printing, and 3D Bioprinting. Have a cool 3D printed Lattice...
Mitigating Litigation Risks with 3D Printing in Life Sciences
With each passing year, the long-predicted aspirational advantages of 3D printing in the life sciences industry become a reality. Forecasts of large scale printing operations at or near...
From Academia: Four-axis 3D printing, Efficacy of 3D printed model for breast cancer reconstruction, and Cultured Meat
“From Academia” features recent, relevant, close to commercialization academic publications in the space of healthcare 3D printing, 3D bioprinting, and related emerging technologies. In this...
Expert's Corner
Mitigating Litigation Risks with 3D Printing in Life Sciences
Before discussing issues specific to each entity in the 3D printing chain, one general issue is exposure created by a lack of established FDA regulations and industry standards. Generally, compliance with FDA, ASTM, and/or ISO regulations and standards are important shields for companies to employ in defense of a lawsuit. Even if your company or entity is not required to comply with FDA regulations, well-established guidance helps companies understand issues and expectations. With 3D printing, however, it does not have the same extensive history or regulatory framework safety net. On December 5, 2017, the FDA adopted the final form of its guidance document on 3D printing entitled “Technical Considerations for Additive Manufacturing.” The guidance does not cover the point of care printing nor bioprinting issues. The guidance does not establish specific requirements but rather describes issues to be considered and addressed by manufacturers during product testing and manufacturing development stages. While the guidance does suggest having procedures and validation processes to address certain issues unique to 3D printing—such as the use of reused materials, software integration, and build path variables—it does not identify any specific “how to’s” for those procedures or tests. Without such guidance or applicable standards, manufacturers are in the unenviable position of having the FDA identify a concern, but not offering any consensus standard for addressing it. ASTM International has developed some consensus standards for additive manufacturing. Committee F42 has developed standards for testing and evaluating methods for the materials used as well for the manufacturing processes. However, there are no specific standards addressing many of the issues and validation processes identified in the FDA’s guidance.
Strategic Issues of 3D Printing in Hospitals - Guide Part 2/5
In part one of this guide, we provided background information on why a beginner's guide to 3D Printing in Hospitals is needed, and how we are organizing our thought process around three main operational management issues. That is, strategic, tactical, and financial issues related to implementing 3D printing in hospitals.
3D Printing In Hospitals: A Beginner's Guide
Over the last five years, there has been significant growth in the adaption of 3D printing in hospitals. This is a result of a more clarifying regulatory landscape, more governmental supports, and new public and private initiatives. Notable relevant public initiatives are led by RSNA SIG group, Mayo Clinic, ASME/SME, FDA, America Makes, ARMI. Notable private initiatives are led by JNJ/Depuy Synthes, GE, HP, Stryker, Medtronics, Lima Corporate, Materialise, Formlabs. The concerted efforts from the private and public sectors resulted in a rapid increase in hospital-based 3D printing labs all over the world. This is further supported by consistently increasing publications on Pubmed. [Figure 1, Source: Pubmed] Within a hospital setting, current major applications remain to be pre-surgical planning, which will comprise the bulk of our discussion. However, lately, there are two defining momentums: point-of-care 3D printing and mass-produced 3D printed implants in the 3D printing healthcare sector, which makes 3D printed personalized implants a possibility for hospital-based 3D printing services. We will incorporate these into our discussion.
Antimicrobial Materials for 3D Printing Medical Devices
This is an Expert's Corner blog by professor Jorge M. Zuniga on the science and applications of antimicrobial materials for additive manufacturing (3D printing) medical devices. The use of copper-based composites to develop antimicrobial materials has been extensively tested in viruses similar to the COVID-19 virus (SARS-CoV-2). In an investigation examining the viral deactivation properties of copper oxide particles infused in N95 respirators6, researchers found that copper oxide’s addition to face-masks resulted in potent anti-influenza properties against human influenza A (H1N1) and avian influenza (H9N2) without altering their physical barrier properties.8,10 When examining the capacity of copper oxide-containing filters to neutralize viruses in suspension, the researchers found that these filters resulted in a significant reduction of the infectious titers, ranging from 1.1 log10 to 4.6 log10 for Yellow Fever, Influenza A virus, Measles, Respiratory Syncytial Virus, Parainfluenza 3, HIV-1, Adenovirus type 1 and Cytomegalovirus.5
3D Bioprinting: The Yellow Brick Road (Part 4)
As we learn to print soft extracellular matrix (ECM) proteins with higher precision (Stage 1 to 2), we will begin to print structures that better recapitulate blood vessels that aid in keeping tissues alive with the assistance of more complicated bioreactors to mature them for implantation (Stage 2 to 3). Stage 4, however, is the furthest level of advancement possible to the point of being science fiction. Much of the difficulty in Stage 3 lies in combining siloed areas of research together into a coherent pipeline. To use a historical example, successfully launching a rocket led to controlling its trajectory which led to returning it to earth intact. These gated steps were each realistic challenges and had all been done in separate lower risk scenarios, but the successful lunar landing in 1969 represented a monumental achievement. Stage 4 bioprinting, however, represents something of jumping to light speed to continue using space exploration as an analogy. In Part 1 of this series we discussed lifting the veil off the headlines surrounding the field to gain a sober view of its future. While the first three parts of this series focused mainly on technical challenges, this final piece is meant to follow through on dispelling some of the more fantastical claims on the potential future of bioprinting a full organ as frequently seen in headlines (Fig. 1).
Expert's Corner: Additive Manufacturing Response to COVID Crisis
In the initial stages of the crisis, the response from the AM community was inspiring and showed a great deal of altruism, passion, and genuine desire to help from major manufacturers to the home hobbyists. It was interesting to see how rapidly the initial enthusiasm for 3D printing all kinds of medical devices was tempered by the realization that the desperation for products or parts (whether perceived or real) could not outweigh the possible risks of non-compliant medical devices. The initial proliferation of ideas was now featuring cautionary posts from academic and industry experts with regulatory or safety experience. This sparked a division in efforts between those companies that had or could quickly achieve medical certification and the very many for whom that would be impossible. This led to the rapid shift towards lower-risk products and a proliferation of designs for Personal Protective Equipment (PPE), which in turn led to a convergence on the production of visors. The speed of convergence on not only the product type but the design was amazing to witness as there was no overall coordination or governmental intervention. It was the natural evolution of design by consensus.